蛋白质氨酸甲基转移酶5通过SRSF1在梅克尔细胞癌中维持Tip60-EP400复合物
Joseph L Sevigny1,2, Evelyn V Proctor1, Heather Adams1
1Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Life science alliance
|August 22, 2025
概括
蛋白质氨酸甲基转移酶5 (PRMT5) 通过修改SRSF1来调节RNA剪接,这对MYCL驱动的癌症中Tip60- EP400复合物的活性至关重要. 抑制PRMT5导致拼接缺陷,提供潜在的治疗策略.
科学领域:
- 分子生物学
- 癌症基因组学
- 表观遗传学
背景情况:
- 蛋白质阿基因甲基转移酶5 (PRMT5) 是基因表达和RNA拼接的关键调节剂.
- 在MTAP被删除的癌症中,PRMT5抑制具有治疗潜力.
- MYC驱动的瘤或野生型TP53瘤也可能对PRMT5抑制产生反应,但机制尚不清楚.
研究的目的:
- 研究PRMT5在调节MYCL驱动的梅克尔细胞癌中的作用.
- 使用RNA-seq和Iso-Seq来描述PRMT5介导的基因表达和替代拼接.
- 阐明PRMT5在拼接调节中的作用背后的分子机制.
主要方法:
- 用RNA测序 (RNA-seq) 来分析PRMT5介导的基因表达.
- 用于深入分析PRMT5介导的替代拼接的Iso-Seq.
- 研究了PRMT5,SRSF1和Tip60- EP400复合体之间的相互作用.
主要成果:
- 通过对SRSF1进行PRMT5修饰,可以增强其对m6A修饰RNA的吸收,从而确保适当的KAT5 (Tip60) 拼接和Tip60- EP400活性.
- 抑制PRMT5导致广泛的拼接缺陷,包括外跳转和内保留.
- 在PRMT5抑制后观察到SRSF1对m6A修饰RNA的调节中断.
结论:
- 在剪接调节中,特别是MYCL驱动的癌症中,PRMT5起着至关重要的作用.
- 通过影响SRSF1的招募,抑制PRMT5会破坏正常的拼接,从而导致瘤途径的失调.
- 针对PRMT5调节的剪接失调可能是MYC驱动的癌症的治疗策略.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:07MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
02:41Telomeres and Telomerase
24.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
24.0K
01:36Mismatch Repair
40.6K
Overview
40.6K